Property |
Value |
dbo:abstract
|
- {{Ficha de organización| company_name = Bristol-Myers Squibb Company| company_logo = | company_type = Sociedad Anónima | traded_as = NYSE: BMY | foundation = 1887| location = Nueva York, Estados Unidos| key_people = , CEO| industry = Farmacéutica| products = | revenue = US$ 18,8 billones ( FY 2009) | operating_income = US$ 5,34 billones ( FY 2009) | equity = US$ 14,8 billones ( FY 2009) (es)
- {{Ficha de organización| company_name = Bristol-Myers Squibb Company| company_logo = | company_type = Sociedad Anónima | traded_as = NYSE: BMY | foundation = 1887| location = Nueva York, Estados Unidos| key_people = , CEO| industry = Farmacéutica| products = | revenue = US$ 18,8 billones ( FY 2009) | operating_income = US$ 5,34 billones ( FY 2009) | equity = US$ 14,8 billones ( FY 2009) (es)
|
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
| |
dbo:wikiPageRevisionID
| |
dct:subject
| |
rdf:type
| |
rdfs:comment
|
- {{Ficha de organización| company_name = Bristol-Myers Squibb Company| company_logo = | company_type = Sociedad Anónima | traded_as = NYSE: BMY | foundation = 1887| location = Nueva York, Estados Unidos| key_people = , CEO| industry = Farmacéutica| products = | revenue = US$ 18,8 billones ( FY 2009) | operating_income = US$ 5,34 billones ( FY 2009) | equity = US$ 14,8 billones ( FY 2009) (es)
- {{Ficha de organización| company_name = Bristol-Myers Squibb Company| company_logo = | company_type = Sociedad Anónima | traded_as = NYSE: BMY | foundation = 1887| location = Nueva York, Estados Unidos| key_people = , CEO| industry = Farmacéutica| products = | revenue = US$ 18,8 billones ( FY 2009) | operating_income = US$ 5,34 billones ( FY 2009) | equity = US$ 14,8 billones ( FY 2009) (es)
|
rdfs:label
|
- Bristol-Myers Squibb (es)
- Bristol-Myers Squibb (es)
|
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:isPrimaryTopicOf
| |
is prop-es:editorial
of | |
is owl:sameAs
of | |
is foaf:primaryTopic
of | |